Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics

被引:15
作者
Henrich, Timothy J. [1 ]
Lauder, Naudia [2 ]
Desai, Mayur M. [3 ,4 ]
Sofair, Andre N. [4 ,5 ,6 ]
机构
[1] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA
[2] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Epidemiol, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[6] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA
关键词
antiretroviral therapy; substance abuse; intravenous drug use; HIV infection; alcohol abuse;
D O I
10.1007/s10900-007-9069-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this study is to examine the association of alcohol abuse and injection drug use (IDU) with the immunologic and virologic responses to highly active antiretroviral treatment (HAART) in urban community health clinics. The medical records of 293 HIV-infected adult patients who visited either of two urban health clinics in New Haven, Connecticut, from June 2003 to December 2004 were retrospectively reviewed. Changes in mean CD4 lymphocyte counts and undetectable viral loads were compared before and after the initiation of HAART for patients categorized into one of four substance abuse groups: history of neither alcohol abuse nor IDU, alcohol abuse only, IDU only, or both. Unadjusted mean improvements in CD4 count for the four groups were 136, 97, 20, and 27, respectively. In a linear regression model adjusted for age, gender, and baseline CD4 count, history of IDU only (P = 0.037) and a combination of alcohol abuse and IDU (P = 0.038) were associated with a lesser increase in CD4 count after HAART compared with those with neither alcohol nor IDU. No significant associations were found between substance abuse history and changes in detectable viral load. Our results show that many patients at urban health clinics have a history of either injection drug use or alcohol abuse, and that injection drug use is negatively associated with the immunologic response to HAART in urban HIV-infected individuals. This study highlights the importance for clinicians of understanding the negative associations of substance abuse with the treatment response of HIV-infected patients at urban health centers.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 38 条
  • [1] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [2] Nonadherence among HIV-Infected injecting drug users: The impact of social instability
    Bouhnik, AD
    Chesney, M
    Carrieri, P
    Gallais, H
    Moreau, J
    Moatti, JP
    Obadia, Y
    Spire, B
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 : S149 - S153
  • [3] Directly observed therapy for the management of HIV-infected patients in a methadone program
    Conway, B
    Prasad, J
    Reynolds, R
    Farley, J
    Jones, M
    Jutha, S
    Smith, N
    Mead, A
    DeVlaming, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S402 - S408
  • [4] Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women
    Cook, JA
    Grey, D
    Burke, J
    Cohen, MH
    Gurtman, AC
    Richardson, JL
    Wilson, TE
    Young, MA
    Hessol, NA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (07) : 1133 - 1140
  • [5] Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: A EuroSIDA study
    Dragsted, UB
    Mocroft, A
    Vella, S
    Viard, JP
    Hansen, ABE
    Panos, G
    Mercey, D
    Machala, L
    Horban, A
    Lundgren, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01): : 148 - 155
  • [6] Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users
    Egea, JM
    Muga, R
    Sirera, G
    Clotet, B
    Tor, J
    Ardèvol, M
    Rey-Joly, C
    Muñoz, A
    [J]. EPIDEMIOLOGY AND INFECTION, 2002, 129 (02) : 325 - 333
  • [7] Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy
    Ellis, RJ
    Childers, ME
    Cherner, M
    Lazzaretto, D
    Letendre, S
    Grant, I
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) : 1820 - 1826
  • [8] The effect of a multidisciplinary program on HAART adherence
    Frick, Pamela
    Tapia, Kenneth
    Grant, Philip
    Novotny, Martina
    Kerzee, Jane
    [J]. AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 511 - 524
  • [9] Goodkin K, 2004, AIDS, V18, pS87, DOI 10.1097/00002030-200401001-00013
  • [10] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    Hammer, SM
    Squires, KE
    Hughes, MD
    Grimes, JM
    Demeter, LM
    Currier, JS
    Eron, JJ
    Feinberg, JE
    Balfour, HH
    Dayton, LR
    Chodakewitz, JA
    Fischl, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733